EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Design, Synthesis and Biological Evaluation of Novel Gypsogenin Derivatives as Potential Anticancer and Antimicrobial Agents

Safiye Emirdağ iD, Nafia Gökçe Ulusoy iD, Mehran Aksel

Chemistry & Biodiversity · 2024

DOI: 10.1002/cbdv.202400471 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2024. Verfasst von Safiye Emirdağ und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Science Dean's Department of Chemistry, Ege University, 35040, İzmir, Turkey. Hauptthemen laut MEDLINE: Antineoplastic Agents, Cell Proliferation, Drug Design, Drug Screening Assays, Antitumor. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Scientific Research Projects of Ege University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Natural compounds are important sources for the treatment of chronic disorders such as cancer and microbial infectious disorders. In this research, Gypsogenin and its derivatives ( 2 a – 2 f ) have been tested against different cancer cell lines (MCF‐7, HeLa, Jurkat and K562 cell lines) and further analyzed for cell proliferation, cell death type, and for act of the mechanism. Cell proliferation was determined by the MTT method and cell death types were analyzed with HO/PI staining. Fibroblast Growth Factor 1 (FGF‐1), Interleukin 1 (IL‐1), Interleukin 6 (IL‐6), and Tumor Necrosis Factor Alpha (TNF‐α), key players in breast cancer development and progression, were determined by Elisa kits. Results showed that compound 2 e inhibited the MCF‐7 cell line proliferation with an IC50 value of 0.66±0.17 μM with 93.38 % apoptosis rate. Compound 2 e also decreased FGF‐1, IL‐1, IL‐6, and TNF‐α levels. Molecular docking studies performed in the binding site of FGFR‐1 indicated that compound 2 e formed key hydrogen bonding with Arg627 and Asn568. Besides, compounds 2 a – 2 f were evaluated for their antimicrobial activities against gram‐negative and gram‐positive bacteria and C. albicans via the microdilution method. Overall, compound 2 e stands out as a potential anticancer agent for future studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsCell ProliferationDrug DesignDrug Screening Assays, AntitumorMicrobial Sensitivity TestsSaponinsHumansAnti-Bacterial AgentsAnti-Infective AgentsAntifungal AgentsApoptosisCandida albicansCell Line, TumorDose-Response Relationship, DrugGram-Negative BacteriaGram-Positive BacteriaMolecular Docking SimulationMolecular StructureStructure-Activity Relationship

Stichwörter der Autor:innen

anticancer activityapoptosisgypsogeninmolecular dockingsemi-synthesis

Substanzen

Anti-Bacterial AgentsAnti-Infective AgentsAntifungal AgentsAntineoplastic AgentsgypsogeninSaponins

Autor:innen und Institutionen

  • Faculty of Science Dean's Department of Chemistry, Ege University, 35040, İzmir, Turkey.
  • Department of Biophysics, Faculty of Medicine, Aydın Adnan Menderes University, 09010, Aydin, Turkey.

ORCID-Profile: Safiye Emirdağ, Nafia Gökçe Ulusoy

Förderung

  • Scientific Research Projects of Ege University

Zitieren

APA

Emirdağ, S., Ulusoy, N. G., & Aksel, M. (2024). Design, Synthesis and Biological Evaluation of Novel Gypsogenin Derivatives as Potential Anticancer and Antimicrobial Agents. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202400471

Vancouver

Emirdağ S, Ulusoy NG, Aksel M. Design, Synthesis and Biological Evaluation of Novel Gypsogenin Derivatives as Potential Anticancer and Antimicrobial Agents. Chemistry & Biodiversity. 2024. doi:10.1002/cbdv.202400471

BibTeX
@article{Emirda2024,
  author = {Emirdağ, Safiye and Ulusoy, Nafia Gökçe and Aksel, Mehran},
  title = {Design, Synthesis and Biological Evaluation of Novel Gypsogenin Derivatives as Potential Anticancer and Antimicrobial Agents},
  journal = {Chemistry & Biodiversity},
  year = {2024},
  doi = {10.1002/cbdv.202400471}
}
Kostenlos starten →